BioSpace News Archive

Press Releases

Fennec Pharmaceuticals to Participate in Upcoming September 2024 Investor Conferences

September 5, 2024
·
1 min read
Press Releases

Pharvaris Provides Business Update and Expands Development Program for Deucrictibant

September 5, 2024
·
10 min read
Press Releases

Immunovant to Host Graves’ Disease Program Update on September 9, 2024

September 5, 2024
·
1 min read
Business

Aurora Spine Corporation to Attend Latin America Pain Society (LAPS) Conference, Showcasing Innovations in Pain Management and Spine Care for Emerging Markets

September 5, 2024
·
3 min read
FDA

THINK Surgical Receives FDA 510(k) Clearance for Zimmer Biomet Persona Knee on TMINI® Miniature Robotic System

September 5, 2024
·
1 min read
News

Atsena Therapeutics Announces 12-Month Safety and Efficacy Data from Phase I/II Clinical Trial of ATSN-101 in LCA1 Published in The Lancet

September 5, 2024
·
5 min read
FDA

Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

September 5, 2024
·
19 min read
Press Releases

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 4, 2024

September 5, 2024
·
1 min read
Press Releases

DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

September 5, 2024
·
2 min read
Press Releases

Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024

September 5, 2024
·
5 min read